XRCC3 polymorphisms have been associated with melanoma (Winsey et al, 2000), bladder cancer (Matullo et al, 2001a; Stern et al, 2002) and SCCHN (Shen et al, 2002). Here, XRCC3 is linked to urinary bladder cancer.